Clinical Trial Services & Solutions Sourcing Center
According to the Alliance of Regenerative Medicine, there were 1,220 clinical trials ongoing at the end of 2020, with 152 of those trials in Phase 3, supporting the FDA's and EMA's predictions they will approve 10-20 cell and gene therapies each year by 2025.
The development of cell and gene therapy trials is both complex and challenging as well as subject to heavy regulatory scrutiny. As new and emerging biotechs and even established pharma drive their research forward through clinical trials, anticipating challenges can be key to bringing therapies from bench to bedside. Biotechs will be faced with important decisions when it comes to clinical development and selecting the right CRO partner is one of those decisions.
How can we help?
Looking for help with your Cell & Gene Therapy clinical trial? If you're searching for information or a supplier, let Life Science Connect lend you a hand.
Applied Biosystems by Thermo Fisher Scientific, qPCR
For reproducible results, choose reliable qPCR reagents. Optimized real-time PCR (qPCR) analysis enables sensitive and specific quantification of nucleic acids. Reagent selection plays a critical role in any qPCR or RT-qPCR protocol to help ensure optimal performance and reliable results. Set your analysis up for success by choosing an Applied Biosystems real-time PCR master mix or reagent.
Avance Clinical
Avance Clinical is a full-service CRO with over three decades of experience, offering high-quality clinical research services across Australia, New Zealand, Asia, North America, and Europe. We specialize in guiding biotechs from pre-clinical development to late-phase studies, with our ClinicReady team for early phases and GlobalReady team for Phase II to III, ensuring expert support at every stage.
Capabilities
inSeption Group
inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.
Have questions about your Cell & Gene therapy clinical trial?
The Life Science Connect team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
MRN – Medical Research Network
At MRN we understand the complexities of today's clinical trial environment and the burden this places on patients, clients and sites.
Our services are designed to ease these burdens, from community researchers through to investigator site professional support, accelerating patient recruitment and retention.
We work to maximize the efficiency of clinical trials for drug developers, by improving the patient's experience, no matter where their community is in the world.
Novotech
Novotech leverages its therapeutic and regulatory expertise, client-centric service model, local market insights, and advanced analytical tools to expedite patient recruitment, enhance trial efficiencies, and bring life-changing therapies to market faster.
Capabilities
OpenClinica
OpenClinica is transforming healthcare through innovative cloud technology that simplifies running clinical trials. Proven in over 10,000 studies worldwide, the OpenClinica platform is trusted by leading biopharmaceutical companies, contract research organizations, academic institutions, and government agencies. OpenClinica is used across a wide spectrum of clinical research, including drug, device, and diagnostic trials, global health studies involving 200,000+ patients, adaptive platform trials, and clinical trials for some of the first gene therapies to be approved for market.
Capabilities
Roche CustomBiotech
Our Roche-quality raw materials are exceptionally well-suited for innovative therapeutic approaches, like mRNA and cell therapies. We complement high-quality content with dedicated tools to monitor, analyze and demonstrate the efficacy and fidelity of manufacturing processes. Our instruments and kits constitute a comprehensive infrastructure to not only meet product release criteria but also ensure maximal production output in a cost and time-efficient manner.
Capabilities
Synthego Corporation
Synthego is a genome engineering company that enables life science research and therapy development with a mission of increased access to engineered therapies for all patients. With unparalleled CRISPR expertise, state-of-the-art GMP capabilities, and a continuum of product offerings, Synthego supports CRISPR-edited cell and gene therapeutic development at every step, from R&D through IND submission to first-in-human trials.
Capabilities
Veristat
Veristat, the Science-First™ full service CRO and consultancy, enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development onto regulatory approval and post-marketing. With our focus on novel drug development and 30 years of experience in clinical trial planning and execution, we deliver bold approaches that make the impossible possible.
Capabilities